Entasis Therapeutics Holdings Inc.
ETTX
ETTX was delisted on the 8th of July, 2022.
22 hedge funds and large institutions have $21.8M invested in Entasis Therapeutics Holdings Inc. in 2020 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 3 closing their positions.
67% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 3
10% more funds holding
Funds holding: 20 → 22 (+2)
0% more capital invested
Capital invested by funds: $21.8M → $21.8M (+$49K)
0% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$170K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$95.7K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$23.9K |
| 4 |
BG
Bollard Group
Boston,
Massachusetts
|
+$16.5K |
| 5 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
+$9.14K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FM
Frazier Management
Seattle,
Washington
|
-$1.91M |
| 2 |
Blackstone Inc
New York
|
-$746K |
| 3 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$109K |
| 4 |
BlackRock
New York
|
-$9.15K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$6.83K |
ETTX Hedge Fund Activity: Q2 2020 in Review
22 of the 4,888 institutional investors tracked by Wall St. Rank reported a position in Entasis Therapeutics Holdings Inc. (ETTX) for Q2 2020, worth a combined $21.8M — up 0.23% from $21.8M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new ETTX positions and 3 closed out — a net gain of 2 holders — while 5 added to existing stakes and 5 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $170K. The largest seller was Frazier Management, cutting an estimated $1.91M.
- 22 institutional investors held Entasis Therapeutics Holdings Inc. (ETTX) as of Q2 2020, up from 20 in Q1 2020.
- Funds reported $21.8M of Entasis Therapeutics Holdings Inc. stock for Q2 2020, up 0.23% quarter-over-quarter.
- 5 funds opened new Entasis Therapeutics Holdings Inc. positions in Q2 2020 and 3 closed out, a net change of +2 holders.
- The largest Entasis Therapeutics Holdings Inc. buyer in Q2 2020 was Renaissance Technologies, an estimated $170K added.
- The largest Entasis Therapeutics Holdings Inc. seller in Q2 2020 was Frazier Management, an estimated $1.91M sold.
Based on aggregated 13F filings for Q2 2020.